Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Oslo University Hospital
With
University Hospital, Akershus
Addis Ababa University
St. Paul's Hospital Millennium Medical College, Ethiopia
South-Eastern Norway Regional Health Authority
Bærum Hospital, Norway
Drammen Hospital, Norway
Tønsberg Hospital, Norway
Helse Stavanger HF
Ålesund Hospital, Norway
Bodø Hospital, Norway
Hvidovre University Hospital
Karolinska University Hospital
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults (18-70 years) with HBeAg negative chronic hepatitis B
HBeAg negative at start of antiviral therapy
Treated minimum 2 years with either tenofovir or entecavir without interruption (i.e. no self-reported episodes of ≥2 weeks off therapy)
Full viral suppression \>2 years: at least 3 measurements at least 6 months apart with at least 24 months between the first and last measurement.
Most recent liver fibrosis assessment, performed within the past 12 months, does not show advanced fibrosis (i.e. Metavir score \<F3 or Fibroscan \<9 kPa). For the (few) patients who lack pre-treatment fibrosis assessment, a more conservative Fibroscan threshold of \<8 kPa will apply.
You may not be if
A history of decompensated liver disease, either by clinical signs (ascites, encephalopathy, portal hypertension, jaundice) or suggestive laboratory results (total bilirubin \>38 umol/L, INR \>1.5, platelets \<75,000/mm3, serum albumin \<30 g/L).
Any previous diagnosis of cirrhosis, either by liver biopsy (Metavir score F4) or elastography (Fibroscan \>12 kPa). Elastography results with concomitant ALT \>200 U/L are not considered.
Previous hepatocellular carcinoma (HCC).
Co-infections with HIV, hepatitis C or hepatitis D.
Other disease or medication that can interfere with the study (e.g. ongoing alcohol or illicit drug abuse, immunosuppressive medication, other active liver disease, or any other condition which in the opinion of the physician is incompatible with participation)